首页> 中文期刊> 《重庆医学》 >血浆B型钠尿肽与心脏肌钙蛋白T在非ST段抬高型急性冠状动脉综合征诊断及预后的评估价值

血浆B型钠尿肽与心脏肌钙蛋白T在非ST段抬高型急性冠状动脉综合征诊断及预后的评估价值

         

摘要

目的 探讨血浆B型钠尿肽(BNP)与心脏肌钙蛋白T(cTnT)在非ST段抬高型急性冠状动脉综合征(NSTE-ACS)诊断及预后评估价值.方法 选择2004年1月至2012年1月该院收治的NSTE-ACS患者286例,BNP≥80 pg/mL患者172例为A组,BNP<80 pg/mL患者114例为B组,比较两组患者的临床资料.结果 A组入院即刻、6、12、24、48 h的血清BNP、血浆cTnT水平高于B组(P<0.05).结论 在临床中结合cTnT和BNP水平检测,可应用于NSTE-ACS患者诊断和预后的判断.%Objective To explore the diagnostic and prognostic value of plasma B-type natriuretic peptide(BNP) and cardiac tro-ponin T(cTnT) in non-ST elevation acute coronary syndrome(NSTE-ACS). Methods 286 patients with NSTE-ACS in this hospital from January 2004 to January 2011 were selected and divided into two groups,172 cases of plasma BNP≥80 pg/mL as the group A and 114 cases of plasma BNP<80 pg/mL as the group B. The clinical data were compared between the two groups. Results Plasma BNP and serum cTnT immediately after admission,at 6,12,24,48 h in the group A were higher than those in the group B(P<0. 05). Conclusion Combined detection of plasma BNP and cTnT in clinic can be used to judge the diagnosis and prognosis of NSTE-ACS.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号